Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Oragenics, Inc. (OGEN) had Consolidated Net Income/Loss of $-2.22M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.22M |
|
-- |
|
-- |
|
$2.03M |
|
$-2.03M |
|
$-0.19M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
|
Consolidated Net Income/Loss |
$-2.22M |
$-2.22M |
|
$-2.03M |
|
$-1.83M |
|
18.22M |
|
18.22M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$3.87M |
|
-- |
|
-- |
|
$3.87M |
|
$3.73M |
|
-- |
|
-- |
|
$3.73M |
|
$0.14M |
|
$0.14M |
|
$0.14M |
|
21.48M |
|
| Cash Flow Statement Financials | |
$-2.11M |
|
-- |
|
$4.67M |
|
$0.86M |
|
$3.42M |
|
$2.56M |
|
$-0.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.04 |
|
-- |
|
-- |
|
-- |
|
18.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1610.07% |
|
-1610.15% |
|
-57.30% |
|
-1610.16% |
|
$0.01 |
|
$-0.12 |
|
$-0.12 |
|